Anvilab Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Anvilab General Information

Description

Manufacturer of generic pharmaceutical products. The company owns the rights to sell Antigrippin-Maximum, Gepagard, and Inflyunet, pharmaceutical brands and owns the trademark Laborotoria ANVI. It develops life saving drugs for chemotherapy, antiviral and others.

Contact Information

Website
www.anvilab.ru
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Corporate Office
  • Kashirskoye Sh. 22, Building 4
  • Moscow
  • Russia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anvilab Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anvilab‘s full profile, request access.

Request a free trial

Anvilab FAQs

  • When was Anvilab founded?

    Anvilab was founded in 2007.

  • Where is Anvilab headquartered?

    Anvilab is headquartered in Moscow, Russia.

  • What industry is Anvilab in?

    Anvilab’s primary industry is Pharmaceuticals.

  • Is Anvilab a private or public company?

    Anvilab is a Private company.

  • What is the current valuation of Anvilab?

    The current valuation of Anvilab is 000.00.

  • What is Anvilab’s current revenue?

    The current revenue for Anvilab is 00000.

  • When was Anvilab acquired?

    Anvilab was acquired on 06-Jul-2011.

  • Who acquired Anvilab?

    Anvilab was acquired by Protek (Distribution & Retail).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »